approval · primary record
CEFAZOLIN SODIUM
3 approval events · latest 2026-08-31
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-08-31 |
| Approval events | 3 |
| Brand | CEFAZOLIN IN DEXTROSE |
| Sponsor | BAXTER HLTHCARE CORP |
| Route | INTRAVENOUS |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-08-31 | FDA | NDA | CEFAZOLIN IN DEXTROSE | BAXTER HLTHCARE CORP | INTRAVENOUS |
| 2026-02-13 | FDA | NDA | CEFAZOLIN SODIUM | HQ SPCLT PHARMA | INTRAVENOUS |
| 2025-01-17 | FDA | NDA | CEFAZOLIN AND DEXTROSE | B BRAUN | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:29:36.370Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:cefazolin-sodium
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cefazolin Sodium · compound